Dyax (DYAX) Return on Equity ROE from the third quarter 2015 to third quarter 2014 and annually, average high and low, overall ranking from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dyax Corp  (DYAX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Dyax's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Dyax in the third quarter 2015?
Dyax Corp recorded a cumulative net loss of $-30 million during 12 months ending in the third quarter 2015, resulting in a negative return on equity (ROE) of -14.14%.

Within the Medical Laboratories industry 9 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2015 from 0 to 3068.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Equity Change 199.15 % 208.06 % -1.38 % 301.96 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -30 -19 -13 -12 -18
Return On Equity (TTM) -14.14 % -11.93 % -12.93 % -11.39 % -20.77 %
DYAX's Total Ranking # 3068 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 314 317 102 106 105
Seq. Equity Change -0.85 % 211.43 % -3.74 % 0.65 % 2.11 %
Seq. Net Income Change - - - - -

Back to DYAX Management Effectiveness >> DYAX's 5 Years Annual ROE >> Compare DYAX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 10
Sector # 199
Overall # 3068

Return On Equity Statistics
High Average Low
-11.39 %
-46.95 %
-210.2 %
(Dec 31 2014)   (Mar 31 2014)





DYAX Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011
Total Equity in Millions 106 26 -52 -27 0
Y / Y Equity Change 301.96 % - - - -
Net Income in Millions -12 -28 -29 -35 0
Y / Y Net Income Change - - - - -
Return On Equity -11.23 % -105.53 % - - -

Back to DYAX Management Effectiveness >> DYAX's 5 Years Annual ROE >> Compare DYAX ROE to its Competitors




More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DYAX's' Return on Equity at Yahoo Finance
DYAX's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DYAX's Competitors
Subscribers only: Roe for Dyax's Suppliers
Subscribers only: Return On Equity for DYAX's Customers




Companies with similar Return On Equity at Sep 30 2015, within Healthcare Sector ROE

Date modified: 2026-08-29T13:43:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.